Publications

Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series  (2022)

Authors:
Wieczorek, Michele; Mariotto, Sara; Ferrari, Sergio; Mosna, Federico; Micò, Maria Caterina; Borghero, Carlo; Dubbini, Maria Vittoria; Malagola, Michele; Skert, Cristina; Andreini, Angelo; De Marco, Beatrice; Polo, Diana; Tfaily, Ahmad; Krampera, Mauro; Grassi, Anna; Candoni, Anna; Ranzato, Federica; Volonghi, Irene; Quatrale, Rocco; Benedetti, Fabio; Tecchio, Cristina
Title:
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series
Year:
2022
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
A Stampa
Referee:
Name of journal:
Bone Marrow Transplantation
ISSN of journal:
0268-3369
N° Volume:
57
Number or Folder:
7
Page numbers:
1133-1141
Keyword:
Diseases; Medical research
Short description of contents:
Neurological complications (NCs) represent a diagnostic and clinical challenge in allogeneic hematopoietic stem cell transplant (alloHSCT) patients. We retrospectively analyzed NC incidence, etiology, timing, characteristics, outcome, and long-term effects in 2384 adult patients transplanted in seven Italian institutions between January 2007 and December 2019. Ninety-three (3.9%) patients were affected by 96 NCs that were infectious (29.2%), immune/inflammatory (26%), drug-related (12.5%), cerebrovascular (5.2%), metabolic (3.1%), related to central nervous system disease relapse (11.5%) and malignancy (3.1%), or undefined (9.4%). Six patients (6.4%) had neurological manifestations of chronic graft-versus-host disease (GVHD). NCs occurred on average at day +128 (from -5 to +4063). Early (< day +120) and late NCs had similar frequencies (46.9% vs 53.1%, p = 0.39). Thirty-one patients (33.3%) were affected by acute or chronic GVHD at the NC onset. With a median follow-up of 25.4 (0.4-163) months, the overall mortality due to NCs was 22.6%. The median time between NC onset and death was 36 (1-269) days. Infectious NCs were the main cause (61.9%) of NC-related mortality. A persistent neurological impairment occurred in 20.4% patients, 57.9% of whom being affected by immune/inflammatory NCs. This study highlights the rare, yet severe impact of alloHSCT-associated NCs on patient survival and long-term functional ability.
Web page:
https://doi.org/10.1038/s41409-022-01690-x
Product ID:
126295
Handle IRIS:
11562/1063849
Last Modified:
November 15, 2022
Bibliographic citation:
Wieczorek, Michele; Mariotto, Sara; Ferrari, Sergio; Mosna, Federico; Micò, Maria Caterina; Borghero, Carlo; Dubbini, Maria Vittoria; Malagola, Michele; Skert, Cristina; Andreini, Angelo; De Marco, Beatrice; Polo, Diana; Tfaily, Ahmad; Krampera, Mauro; Grassi, Anna; Candoni, Anna; Ranzato, Federica; Volonghi, Irene; Quatrale, Rocco; Benedetti, Fabio; Tecchio, Cristina, Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series «Bone Marrow Transplantation» , vol. 57 , n. 72022pp. 1133-1141

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share